Previous Close | 0.0500 |
Open | 0.0937 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0681 - 0.0937 |
52 Week Range | 0.0233 - 0.5610 |
Volume | |
Avg. Volume | 5,498 |
Market Cap | 5.635M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0660 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App, has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’ comments
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private Placement”). Each
VANCOUVER, British Columbia, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. After a successful launch on the Apple App Store, Treatment’s revolutionary symptom assessment tool, Treatment Digital Health App, is now available to millions more smart